Several studies have reported a reduction of the incidence and rate of the cognitive decline in AD after starting treatment with RAS-acting antihypertensive drugs (ACE inhibitors) and angiotensin receptor blockers (ARB) [18]. The gene discussed is ACE; the disease is Alzheimer disease.